Formative research for the design of a scalable water, sanitation, and hygiene mobile health program: CHoBI7 mobile health program


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
31 07 2019
Historique:
received: 08 11 2018
accepted: 10 06 2019
entrez: 2 8 2019
pubmed: 2 8 2019
medline: 2 11 2019
Statut: epublish

Résumé

The Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) is a handwashing with soap and water treatment intervention program delivered by a health promoter bedside in a health facility and through home visits to diarrhea patients and their household members during the 7 days after admission to a health facility. In a randomized controlled trial among cholera patient households in Bangladesh, the 7-day CHoBI7 program resulted in a significant reduction in cholera among household members of cholera patients and sustained improvements in drinking water quality and handwashing with soap practices 12 months post-intervention. In an effort to take this intervention to scale across Bangladesh in partnership with the Bangladesh Ministry of Health and Family Welfare, this study evaluates the feasibility and acceptability of mobile health (mHealth) programs as a low-cost, scalable approach for CHoBI7 program delivery. Formative research for the development of the CHoBI7 mHealth intervention included 40 semi-structured interviews, 4 mHealth workshops, 2 group discussions, and a pilot study of 52 households to assess the feasibility and acceptability of the developed mHealth program. Thematic analysis of the interviews and group discussions was conducted by two individuals separately based on emergent themes, and then themes were compared and discussed. A theory- and evidence-based approach using qualitative research methods was implemented to design the CHoBI7 mHealth program. Semi-structured interviews with government stakeholders identified perceptions and preferences for scaling the CHoBI7 mHealth program. Group discussions and semi-structured interviews with diarrhea patients and their family members identified beneficiary perceptions of mHealth and preferences for CHoBI7 mHealth program delivery. mHealth workshops were conducted as an interactive approach to draft and refine mobile message content based on stakeholder preferences. The pilot findings indicate that the CHoBI7 mHealth program has high user acceptability and is feasible to deliver to diarrhea patients that present at health facilities for treatment in Bangladesh. Both text and voice messages were recommended for program delivery. Dr. Chobi, the sender of mHealth messages, was viewed as a credible source of information that could be shared with others. This study presents a theory- and evidence-based approach that can be implemented for the development of future water, sanitation, and hygiene mHealth programs in low-resource settings.

Sections du résumé

BACKGROUND
The Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) is a handwashing with soap and water treatment intervention program delivered by a health promoter bedside in a health facility and through home visits to diarrhea patients and their household members during the 7 days after admission to a health facility. In a randomized controlled trial among cholera patient households in Bangladesh, the 7-day CHoBI7 program resulted in a significant reduction in cholera among household members of cholera patients and sustained improvements in drinking water quality and handwashing with soap practices 12 months post-intervention. In an effort to take this intervention to scale across Bangladesh in partnership with the Bangladesh Ministry of Health and Family Welfare, this study evaluates the feasibility and acceptability of mobile health (mHealth) programs as a low-cost, scalable approach for CHoBI7 program delivery.
METHODS
Formative research for the development of the CHoBI7 mHealth intervention included 40 semi-structured interviews, 4 mHealth workshops, 2 group discussions, and a pilot study of 52 households to assess the feasibility and acceptability of the developed mHealth program. Thematic analysis of the interviews and group discussions was conducted by two individuals separately based on emergent themes, and then themes were compared and discussed.
RESULTS
A theory- and evidence-based approach using qualitative research methods was implemented to design the CHoBI7 mHealth program. Semi-structured interviews with government stakeholders identified perceptions and preferences for scaling the CHoBI7 mHealth program. Group discussions and semi-structured interviews with diarrhea patients and their family members identified beneficiary perceptions of mHealth and preferences for CHoBI7 mHealth program delivery. mHealth workshops were conducted as an interactive approach to draft and refine mobile message content based on stakeholder preferences. The pilot findings indicate that the CHoBI7 mHealth program has high user acceptability and is feasible to deliver to diarrhea patients that present at health facilities for treatment in Bangladesh. Both text and voice messages were recommended for program delivery. Dr. Chobi, the sender of mHealth messages, was viewed as a credible source of information that could be shared with others.
CONCLUSION
This study presents a theory- and evidence-based approach that can be implemented for the development of future water, sanitation, and hygiene mHealth programs in low-resource settings.

Identifiants

pubmed: 31366398
doi: 10.1186/s12889-019-7144-z
pii: 10.1186/s12889-019-7144-z
pmc: PMC6670164
doi:

Substances chimiques

Soaps 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1028

Subventions

Organisme : United States Agency for International Development
ID : AID-OAA-F-15-00038
Pays : International

Commentaires et corrections

Type : ErratumIn

Références

Lancet. 2015 Oct 3;386(10001):1362-1371
pubmed: 26164097
BMC Public Health. 2010 Sep 09;10:545
pubmed: 20828412
J Health Commun. 2014;19 Suppl 1:164-89
pubmed: 25207452
Trop Med Int Health. 2018 May;23(5):508-525
pubmed: 29537671
Int J Epidemiol. 2019 Aug 1;48(4):1204-1218
pubmed: 30535198
Soc Sci Med. 2010 Feb;70(3):383-391
pubmed: 19914758
Emerg Infect Dis. 2016 Feb;22(2):233-41
pubmed: 26811968
Am J Med. 2015 Oct;128(10):1139.e1-5
pubmed: 26087045
Am J Infect Control. 2015 Aug;43(8):826-32
pubmed: 26026828
J Med Internet Res. 2010 Feb 17;12(1):e4
pubmed: 20164043
Health Educ Behav. 2017 Aug;44(4):613-625
pubmed: 28071141
BMC Public Health. 2013 Oct 26;13:1015
pubmed: 24160869
Health Psychol. 2010 Jan;29(1):1-8
pubmed: 20063930
J Psychol. 1975 Sep;91(1):93-114
pubmed: 28136248
Soc Sci Med. 2009 Mar;68(6):1006-12
pubmed: 19181428
Lancet Glob Health. 2017 Apr;5(4):e428-e438
pubmed: 28288747
Am J Trop Med Hyg. 2009 Jul;81(1):140-5
pubmed: 19556579
Health Educ Res. 2009 Aug;24(4):655-73
pubmed: 19286894
Lancet Infect Dis. 2017 Sep;17(9):909-948
pubmed: 28579426
Am J Trop Med Hyg. 2016 Feb;94(2):428-36
pubmed: 26728766
Lancet. 2011 Aug 27;378(9793):795-803
pubmed: 21820166
Am J Trop Med Hyg. 2014 Dec;91(6):1190-6
pubmed: 25311693
Health Commun. 2010 Dec;25(8):661-9
pubmed: 21153982
Am J Trop Med Hyg. 2017 Jun;96(6):1382-1387
pubmed: 28719281
Clin Infect Dis. 2009 Nov 15;49(10):1473-9
pubmed: 19842974
Soc Sci Med. 2015 Jan;124:103-14
pubmed: 25461867
Lancet Infect Dis. 2011 Apr;11(4):312-21
pubmed: 21453872
Emerg Infect Dis. 2015 Nov;21(11):2006-13
pubmed: 26484778
PLoS Med. 2013;10(1):e1001362
pubmed: 23349621
Bull World Health Organ. 1981;59(2):263-8
pubmed: 7018729
Int J Environ Health Res. 2012;22(5):431-49
pubmed: 22292899
Am J Trop Med Hyg. 2014 Aug;91(2):415-23
pubmed: 24914003
J Health Psychol. 2014 Dec;19(12):1483-98
pubmed: 23864069
Dev Change. 2011;42(2):499-528
pubmed: 21898946
Epidemiol Rev. 2010;32:56-69
pubmed: 20354039
Int J Environ Res Public Health. 2016 Jan 14;13(1):
pubmed: 26784210
BMC Public Health. 2014 Feb 21;14:188
pubmed: 24555733
Am J Epidemiol. 1996 Mar 15;143(6):608-23
pubmed: 8610678

Auteurs

Christine Marie George (CM)

Associate Professor, Department of International Health, Program in Global Disease Epidemiology and Control, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Room E5535, Baltimore, MD, 21205-2103, USA. cmgeorge1@jhu.edu.

Fatema Zohura (F)

International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.

Alana Teman (A)

Associate Professor, Department of International Health, Program in Global Disease Epidemiology and Control, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Room E5535, Baltimore, MD, 21205-2103, USA.

Elizabeth Thomas (E)

Associate Professor, Department of International Health, Program in Global Disease Epidemiology and Control, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Room E5535, Baltimore, MD, 21205-2103, USA.

Tasdik Hasan (T)

International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.

Sohel Rana (S)

Associate Professor, Department of International Health, Program in Global Disease Epidemiology and Control, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Room E5535, Baltimore, MD, 21205-2103, USA.

Tahmina Parvin (T)

International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.

David A Sack (DA)

Associate Professor, Department of International Health, Program in Global Disease Epidemiology and Control, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Room E5535, Baltimore, MD, 21205-2103, USA.

Sazzadul Islam Bhuyian (SI)

International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.

Alain Labrique (A)

Associate Professor, Department of International Health, Program in Global Disease Epidemiology and Control, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Room E5535, Baltimore, MD, 21205-2103, USA.

Jahed Masud (J)

International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.

Peter Winch (P)

Associate Professor, Department of International Health, Program in Global Disease Epidemiology and Control, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Room E5535, Baltimore, MD, 21205-2103, USA.

Elli Leontsini (E)

Associate Professor, Department of International Health, Program in Global Disease Epidemiology and Control, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Room E5535, Baltimore, MD, 21205-2103, USA.

Kelsey Zeller (K)

Associate Professor, Department of International Health, Program in Global Disease Epidemiology and Control, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Room E5535, Baltimore, MD, 21205-2103, USA.

Farzana Begum (F)

International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.

Abul Hasem Khan (AH)

Ministry of Health and Family Welfare, Dhaka, Bangladesh.

Sanya Tahmina (S)

Ministry of Health and Family Welfare, Dhaka, Bangladesh.

Farazana Munum (F)

Ministry of Health and Family Welfare, Dhaka, Bangladesh.

Shirajum Monira (S)

International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.

Munirul Alam (M)

International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH